Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Chemed Corporation (CHE : NYSE)
 
 • Company Description   
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.

Number of Employees: 15,695

 
 • Price / Volume Information   
Yesterday's Closing Price: $434.61 Daily Weekly Monthly
20 Day Moving Average: 202,218 shares
Shares Outstanding: 14.16 (millions)
Market Capitalization: $6,155.90 (millions)
Beta: 0.43
52 Week High: $623.61
52 Week Low: $408.42
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.07% -1.58%
12 Week -2.36% -6.41%
Year To Date -17.97% -28.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
255 EAST FIFTH STREET SUITE 2600
-
CINCINNATI,OH 45202
USA
ph: 513-762-6690
fax: 513-762-6590
None http://www.chemed.com
 
 • General Corporate Information   
Officers
Kevin J. McNamara - President and Chief Executive Officer
Michael D. Witzeman - Vice President; Chief Financial Officer; and Contr
Ron DeLyons - Directors
Patrick P. Grace - Directors
Christopher J. Heaney - Directors

Peer Information
Chemed Corporation (CMTI)
Chemed Corporation (CMWLQ)
Chemed Corporation (AHG.)
Chemed Corporation (ROIX)
Chemed Corporation (M.DCE)
Chemed Corporation (DHSM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-OUTP/HM CRE
Sector: Medical
CUSIP: 16359R103
SIC: 8082
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/25/26
Share - Related Items
Shares Outstanding: 14.16
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.43
Market Capitalization: $6,155.90 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.55%
Current Fiscal Quarter EPS Consensus Estimate: $6.57 Indicated Annual Dividend: $2.40
Current Fiscal Year EPS Consensus Estimate: $20.43 Payout Ratio: 0.12
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.04
Estmated Long-Term EPS Growth Rate: 8.77% Last Dividend Paid: 08/11/2025 - $0.60
Next EPS Report Date: 02/25/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 21.27
Trailing 12 Months: 21.62
PEG Ratio: 2.43
Price Ratios
Price/Book: 5.72
Price/Cash Flow: 16.90
Price / Sales: 2.43
EPS Growth
vs. Year Ago Period: -7.32%
vs. Previous Quarter: 31.73%
Sales Growth
vs. Year Ago Period: 3.09%
vs. Previous Quarter: 0.99%
ROE
09/30/25 - 25.89
06/30/25 - 25.83
03/31/25 - 27.58
ROA
09/30/25 - 17.59
06/30/25 - 17.77
03/31/25 - 18.96
Current Ratio
09/30/25 - 1.35
06/30/25 - 1.86
03/31/25 - 1.73
Quick Ratio
09/30/25 - 1.33
06/30/25 - 1.83
03/31/25 - 1.70
Operating Margin
09/30/25 - 11.70
06/30/25 - 12.17
03/31/25 - 13.14
Net Margin
09/30/25 - 11.02
06/30/25 - 11.56
03/31/25 - 12.40
Pre-Tax Margin
09/30/25 - 14.64
06/30/25 - 15.44
03/31/25 - 16.50
Book Value
09/30/25 - 76.01
06/30/25 - 82.25
03/31/25 - 80.78
Inventory Turnover
09/30/25 - 203.60
06/30/25 - 190.32
03/31/25 - 177.22
Debt-to-Equity
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©